Board MeetingAug 5, 2026, 09:26 AM
Ascentage Pharma Board to Meet for H1 2026 Results
AI Summary
Ascentage Pharma Group International announced that its Board of Directors will hold a meeting on August 19, 2026. The primary agenda for this meeting is to consider and, if deemed appropriate, approve the unaudited interim financial results for the six months that concluded on June 30, 2026, and to authorize their publication.
Key Highlights
- Board meeting scheduled for Wednesday, August 19, 2026.
- Purpose is to consider and approve unaudited interim results.
- Results are for the six months ended June 30, 2026.
Price Impact
More from AAPG